The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review

Journal of Thrombosis and Haemostasis - Tập 11 - Trang 975-987 - 2013
B. Anandasundaram1, D.A. Lane1, S. Apostolakis1, G.Y.H. Lip1
1University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK

Tài liệu tham khảo

Hughes, 2008, Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost-effectiveness data, Thromb Haemost, 99, 295, 10.1160/TH07-08-0508 2007, Independent predictors of stroke in patients with atrial fibrillation: a systematic review, Neurology, 69, 546, 10.1212/01.wnl.0000267275.68538.8d Gage, 2001, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA, 285, 2864, 10.1001/jama.285.22.2864 Karthikeyan, 2010, The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?, Thromb Haemost, 104, 45, 10.1160/TH09-11-0757 Fuster, 2006, Europace, 8, 651, 10.1093/europace/eul097 Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation, Chest, 137, 263, 10.1378/chest.09-1584 Camm, 2012, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association, Eur Heart J, 33, 2719, 10.1093/eurheartj/ehs253 Depta, 2010, Artherothrombosis and atrial fibrillation: important and often overlapping clinical syndromes, Thromb Haemost, 104, 657, 10.1160/TH10-05-0332 Goto, 2008, Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with artherothrombosis, Am Heart J, 156, 855, 10.1016/j.ahj.2008.06.029 Lip, 2007, Coronary artery disease and ischaemic stroke in atrial fibrillation, Chest, 132, 8, 10.1378/chest.07-0500 Tunick, 1990, Protruding artherosclerotic plaque in the aortic arch of patients with systemic embolisation: a new finding seen by transoesophageal echocardiography, Am Heart J, 120, 658, 10.1016/0002-8703(90)90024-R Tunick, 1994, High risk for vascular events in patients with protruding aortic atheromas: a prospective study, J Am Coll Cardiol, 23, 1085, 10.1016/0735-1097(94)90595-9 Amarenco, 1994, Atherosclerotic disease of the aortic arch and the risk of ischemic stroke, N Engl J Med, 331, 1474, 10.1056/NEJM199412013312202 Frost, 2000, Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation, Am J Med, 108, 36, 10.1016/S0002-9343(99)00415-5 Conway, 2004, Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project), Am J Cardiol, 93, A1410, 10.1016/j.amjcard.2004.02.047 Winkel, 2010, Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Artherothrombosis for Continued Health (REACH) Registry, Eur J Vasc Endovasc Surg, 40, 9, 10.1016/j.ejvs.2010.03.003 Wang, 2003, A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study, JAMA, 290, 1049, 10.1001/jama.290.8.1049 2008, Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation, Stroke, 39, 1901, 10.1161/STROKEAHA.107.501825 Lin, 2011, Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation. A nationwide database analysis, Atherosclerosis, 217, 292, 10.1016/j.atherosclerosis.2011.03.033 Rasmussen, 2011, Impact of vascular disease in predicting stroke, and death in patients with atrial fibrillation:the Danish Diet, Cancer and Health (DCH) cohort study, J Thromb Haemost, 9, 1301, 10.1111/j.1538-7836.2011.04308.x Olesen, 2011, Torp-PedersenC. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study, BMJ, 342, d124, 10.1136/bmj.d124 Olesen, 2012, Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study, Am J Med, 125, 826, 10.1016/j.amjmed.2011.11.024 Olesen, 2012, Risk factors for stroke and thromboembolism in relation to age amongst patients with atrial fibrillation: The Loire Valley Atrial Fibrillation Project, Chest, 141, 147, 10.1378/chest.11-0862 Zabalgoitia, 1998, Transoesophageal echocardiographic correlates of clinical risk of thromboembolism in non-valvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators, J Am Cardiol, 31, 1622, 10.1016/S0735-1097(98)00146-6 Manning, 1998, Transesophageal echocardiography and atrial fibrillation: added value or expensive toy?, Ann Intern Med, 128, 685, 10.7326/0003-4819-128-8-199804150-00013 Blackshear, 1999, Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications, Stroke, 30, 834, 10.1161/01.STR.30.4.834 Petersen, 1990, Risk factors for thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study, Arch Intern Med, 150, 819, 10.1001/archinte.1990.00390160077016 Ezekowitz, 1995, Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The veterans affairs stroke prevention in nonrheumatic atrial fibrillation investigators, Circulation, 92, 2178, 10.1161/01.CIR.92.8.2178 van Walraven, 2003, A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin, Arch Intern Med, 163, 936, 10.1001/archinte.163.8.936 Gallego, 2012, Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation, Eur J Clin Invest, 42, 1302, 10.1111/eci.12004 Violi, 2012, Peripheral artery disease and atrial fibrillation: a potentially dangerous combination, Intern Emerg Med, 7, 213, 10.1007/s11739-011-0637-0 Schmitt, 2009, Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications, Eur Heart J, 30, 1038, 10.1093/eurheartj/ehn579 Wong, 2000, New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience, Am Heart J, 140, 878, 10.1067/mhj.2000.111108 Asanin, 2005, Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction, Eur J Heart Fail, 7, 671, 10.1016/j.ejheart.2004.07.018 Asanin, 2007, Outcome of patients in relation to duration of new-onset atrial fibrillation following acute myocardial infarction, Cardiology, 107, 197, 10.1159/000095417 Pedersen, 1999, The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evaluation, Eur Heart J, 20, 748, 10.1053/euhj.1998.1352 Krarup, 2007, Validity of stroke diagnosis in a National Register of Patients, Neuroepidemiology, 28, 150, 10.1159/000102143 Kirchhof, 2007, Outcome parameters for trials in atrial fibrillation. Recommendations from a consensus conference organised by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association, Europace, 9, 1006, 10.1093/europace/eum191 Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007 Connolly, 2006, Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial, Lancet, 367, 903 Lip, 2008, Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation, BMJ, 336, 614, 10.1136/bmj.39351.706586.AD Lip, 2011, Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis, Thromb Haemost, 106, 997, 10.1160/TH11-10-0690 Huber, 2011, Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe, Thromb Haemost, 106, 569, 10.1160/TH11-08-0602 Faxon, 2011, Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective, Thromb Haemost, 106, 572 You, 2012, Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, e531s, 10.1378/chest.11-2304 Skanes, 2012, Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control, Can J Cardiol, 28, 125, 10.1016/j.cjca.2012.01.021